Afrocentric InvestmentJSE:ACT 52 Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Afrocentric Investment ranks worse than 355871.53% on this metric.
As of today (2026-06-27), the Trailing Annual Dividend Yield of Afrocentric Investment is 0.00%.
The historical rank and industry rank for Afrocentric Investment's Dividend Yield % or its related term are showing as below:
During the past 13 years, the highest Dividend Yield of Afrocentric Investment was 11.58%. The lowest was 0.00%. And the median was 6.30%.
JSE:ACT's Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.4 * Ranked among companies with meaningful Dividend Yield % only.
During the past 12 months, Afrocentric Investment's average Dividends Per Share Growth Rate was -45.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -43.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -30.50% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -9.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Afrocentric Investment was 28.00% per year. The lowest was -43.90% per year. And the median was 3.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Afrocentric Investment Dividend Yield % Related Terms
Afrocentric Investment Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: Dividend Yield % Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Dividend Yield % falls into.
Afrocentric Investment (JSE:ACT) has a Dividend Yield % of 0.00% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Afrocentric Investment and its competitors. According to the industry distribution chart, Afrocentric Investment ranks #999999 out of 281 companies in the Healthcare Providers & Services industry.
Is Afrocentric Investment's Dividend Yield % too high?
Afrocentric Investment's current Dividend Yield % is 0.00%. Based on the distribution chart, Afrocentric Investment ranks #999999 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #999999 out of 281 companies for Dividend Yield %. This places Afrocentric Investment in the lower half of its industry. The industry median Dividend Yield % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Dividend Yield % is 0.00%. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Dividend Yield %: 0.00%
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
